These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8182636)

  • 1. Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia.
    Bakker C; Rutten M; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1994 Feb; 21(2):269-74. PubMed ID: 8182636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient utilities in fibromyalgia and the association with other outcome measures.
    Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1995 Aug; 22(8):1536-43. PubMed ID: 7473480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient utilities in ankylosing spondylitis and the association with other outcome measures.
    Bakker C; Rutten-van Mölken M; Hidding A; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1994 Jul; 21(7):1298-304. PubMed ID: 7966073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problem elicitation to assess patient priorities in ankylosing spondylitis and fibromyalgia.
    Bakker C; van der Linden S; van Santen-Hoeufft M; Bolwijn P; Hidding A
    J Rheumatol; 1995 Jul; 22(7):1304-10. PubMed ID: 7562763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire.
    Perrot S; Dumont D; Guillemin F; Pouchot J; Coste J;
    J Rheumatol; 2003 May; 30(5):1054-9. PubMed ID: 12734906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life issues for fibromyalgia patients.
    Bernard AL; Prince A; Edsall P
    Arthritis Care Res; 2000 Feb; 13(1):42-50. PubMed ID: 11094925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional impairment in spondyloarthropathy and fibromyalgia.
    Heikkilä S; Ronni S; Kautiainen HJ; Kauppi MJ
    J Rheumatol; 2002 Jul; 29(7):1415-9. PubMed ID: 12136899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis.
    Tubach F; Pham T; Skomsvoll JF; Mikkelsen K; Bjørneboe O; Ravaud P; Dougados M; Kvien TK
    Arthritis Rheum; 2006 Dec; 55(6):960-3. PubMed ID: 17139643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis.
    Lubrano E; Sarzi Puttini P; Parsons WJ; D'Angelo S; Cimmino MA; Serino F; Pappone N
    Rheumatology (Oxford); 2005 May; 44(5):666-9. PubMed ID: 15757970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility measures of health-related quality of life in patients treated for benign paroxysmal positional vertigo.
    Roberts RA; Abrams H; Sembach MK; Lister JJ; Gans RE; Chisolm TH
    Ear Hear; 2009 Jun; 30(3):369-76. PubMed ID: 19322083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hungarian adaptation of a disease-specific quality-of-life questionnaire in patients with ankylosing spondylitis].
    Lovas K; Géher P; Whalley D; McKenna S; Meads D; Kaló Z
    Orv Hetil; 2002 Aug; 143(32):1893-7. PubMed ID: 12221995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis.
    Maksymowych WP; Richardson R; Mallon C; van der Heijde D; Boonen A
    Arthritis Rheum; 2007 Feb; 57(1):133-9. PubMed ID: 17266072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-based utilities for bipolar disorder-related health states.
    Revicki DA; Hanlon J; Martin S; Gyulai L; Nassir Ghaemi S; Lynch F; Mannix S; Kleinman L
    J Affect Disord; 2005 Aug; 87(2-3):203-10. PubMed ID: 16005983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Symptoms, effects on quality of life, judgement and expectations of treatment in active ankylosing spondylitis: the patient's view].
    Falkenbach A; Curda B
    Rehabilitation (Stuttg); 2001 Oct; 40(5):275-9. PubMed ID: 11579374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological issues of patient utility measurement. Experience from two clinical trials.
    Rutten-van Mölken MP; Bakker CH; van Doorslaer EK; van der Linden S
    Med Care; 1995 Sep; 33(9):922-37. PubMed ID: 7666706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health related utility measurement: an introduction.
    Bakker C; van der Linden S
    J Rheumatol; 1995 Jun; 22(6):1197-9. PubMed ID: 7674256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life of patients with ankylosing spondylitis in Canada.
    Kobelt G; Andlin-Sobocki P; Maksymowych WP
    J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives.
    Spoorenberg A; van Tubergen A; Landewé R; Dougados M; van der Linden S; Mielants H; van de Tempel H; van der Heijde D
    Rheumatology (Oxford); 2005 Jun; 44(6):789-95. PubMed ID: 15757962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and reliability of a mailed questionnaire to obtain visual analogue scale valuations for health states defined by the Health Utilities Index Mark 3.
    Raat H; Bonsel GJ; Hoogeveen WC; Essink-Bot ML;
    Med Care; 2004 Jan; 42(1):13-8. PubMed ID: 14713735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibromyalgia: its prevalence and impact on the quality of life on a hemodialyzed population.
    Couto CI; Natour J; Carvalho AB
    Hemodial Int; 2008 Jan; 12(1):66-72. PubMed ID: 18271844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.